N@N

Graig Suvannavejh Initiated (AXSM) at Strong Buy and Held Target at $76 on, Sep 7th, 2022

Graig Suvannavejh of Mizuho, Initiated "Axsome Therapeutics, Inc." (AXSM) at Strong Buy and Held Target at $76 on, Sep 7th, 2022.

Graig has made no other calls on AXSM in the last 4 months.

There are 5 other peers that have a rating on AXSM. Out of the 5 peers that are also analyzing AXSM, 1 agrees with Graig's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $75 on, Tuesday, August 30th, 2022

These are the ratings of the 4 analyists that currently disagree with Graig

---

• Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $210 on, Tuesday, August 23rd, 2022
• Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $75 on, Monday, August 22nd, 2022
• Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $64 on, Wednesday, June 29th, 2022
• Joseph Thome of "Cowen & Co." Maintained at Buy with Increased Target to $130 on, Wednesday, June 29th, 2022

Contributing Sources

---